Authors


Maria Yu, MA

Latest:

Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.


Shyam Gelot, PharmD, BCPS

Latest:

Apixaban: A New Treatment Option for Cancer-Associated VTE

Optimizing the best pharmaceutical agent while minimizing adverse effects is paramount in patients with cancer-associated venous thromboembolism.


Dan Steiber, RPh Specialty Pharmacy Times Editor-in-Chief

Latest:

NASP Meeting Shines Light on Challenges, Opportunities in Specialty Pharmacy

NASP maintains a strong focus on policies affecting the national, legislative, and regulatory landscape of specialty pharmacy year round.


Steven D. Gore, MD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.



Marc O’Connor

Latest:

Value-Based Contracts and Health Systems Specialty Pharmacy Integration: 2 Key Insights From Asembia 2017

The summit provides a place for specialty pharmacy stakeholders to discuss the industry.


Lee Goldberg, MBA

Latest:

Rapid Deployment of Prior Authorization Policies

In an effort to minimize the cost curve, payers have been adjusting their utilization management policies, spurred by the approval of several costly new hepatitis C medications.


Aaron Smith

Latest:

How to Manage the Symptoms of Autoimmune Disease

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.


Joel L. Zive, PharmD, AAHIVP

Latest:

Chaotic Health Care Landscape Breeds Opportunity for Pharmacists

In the current chaotic environment of reimbursement that depends on quality and cost savings, pharmacists should increase their presence.


Keith McGee

Latest:

Delivering on the Potential of the Specialty Pipeline: 3 Disruptive Trends in Specialty Pharmacy

Pharmacy stakeholders must be nimble and responsive to innovations and disruptive trends in the market.


Gordon Vanscoy, PharmD, MBA

Latest:

Rare Pharmacy Emerges From Specialty, Part 3

The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.



Kathleen O'Dell CPhT, Lindsay Crawford, PharmD, BCPS

Latest:

New ACT Program Brings Challenges and Barriers

Boise VA Medical Center in Idaho develops an accuracy checking technician service and shares lessons from the implementation.


Jaqueline Rogerio, MD

Latest:

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.


Steven Silverstein, PharmD, BCPS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.



Calvin Eng, MD

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.


Sibyl Cherian, PharmD

Latest:

Establishing Standards of Care for Amiodarone Monitoring in an Outpatient Setting

Implementing a quality-improvement project that allows for education and interdisciplinary collaboration among pharmacists, cardiologists, and primary care providers can improve rates of amiodarone monitoring.


Han Nguyen, PharmD Candidate

Latest:

Summary of Current SARS-CoV-2 Vaccine Trials

Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.


Jeffrey B. Weilburg, MD

Latest:

Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control

Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.



Bimal V. Patel, PharmD, MS

Latest:

E-Prescribing With Decision Support Is Associated With Improvements in Medication Adherence

This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.


Julia Spiridigliozzi, PharmD

Latest:

An Introduction to Pharmaceutical Industry Fellowships

With the current increase in pharmacy school enrollment contributing to a more competitive job market, novel and nontraditional career paths may become a more viable option for pharmacy school graduates.


Sooyeon Kwon, PharmD, PhD

Latest:

Exercise Caution Amid the COVID-19 Pandemic

Panic and a host of interactions are entwined with disease-modifying antirheumatic drugs.


Natalie Boytsov, PhD

Latest:

Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.



Adam Grana, Frederick Bentzel

Latest:

LinkedIn to Pharmacy: A Student Pharmacist's Guide

Developing industry connections is crucial for aspiring pharmacists.


Ivan Navarro, PharmD candidate

Latest:

Technicians Report Challenges, Successes with ABM Medication Synchronization

The Appointment Based Model (ABM) is a type of medication synchronization where patients have 1 or 2 appointed days a month to pick up their medications.


Paula Bickley, Vice President of Market Access, Biologics by McKesson

Latest:

To Optimize the Patient Journey, Put the Patient First

Without coordinated care to ensure proper adherence, the resulting costs can become downright staggering for health systems.


Bridget T. Regan, MBA, RPh

Latest:

Partnered for Postgraduate Success – SPT & MSPBA

The University of Pittsburgh’s Masters of Science in Pharmacy Business Administration program catalyzes the critical skills and expertise necessary for students to reach their professional goals.